Why the Nike Selloff? - TheStreet.com thumbnail
Business

Why the Nike Selloff? – TheStreet.com

Shares of Nike (NKE)  on Friday morning will trade at a discount to Thursday’s closing price. The firm reported fiscal third quarter financial results that beat expectations for earnings per share by three cents on revenue that printed in-line with industry consensus. Though the shares sold-off over night, there is a lot of good in […]

FiercePharmaAsia—Aducanumab Alzheimer's flop; Keytruda's Chinese market; Samsung BioLogics probe - FiercePharma thumbnail
Business

FiercePharmaAsia—Aducanumab Alzheimer’s flop; Keytruda’s Chinese market; Samsung BioLogics probe – FiercePharma

Biogen’s and Eisai’s stocks were dealt a huge blow as the phase 3 program of Alzheimer’s candidate aducanumab was terminated early for futility. Despite challenges from lower-priced domestic rivals, Merck & Co.’s Keytruda could still see blockbuster sales in China, a group of analysts said. Prosecutors raided Korea Exchange as part of an investigation into Samsung […]

Is Micron a Buy? Friday's Trading Will Provide the Answer - TheStreet.com thumbnail
Business

Is Micron a Buy? Friday’s Trading Will Provide the Answer – TheStreet.com

On Wednesday night, Micron Technology (MU) reported fiscal second-quarter earnings of $1.71 per share on revenue of $5.84 billion. Both results exceeded expectations by a small margin. Despite guiding third-quarter revenue and EPS below expectations, the shares have traded higher. How soft was guidance? Management foresees revenue around $4.8 billion and EPS between $0.75 to […]